SOLARA ACTIVE PHARMA SCIENCES LIMIT

Solara Active Pharma Sciences Limited Company Introduction

Solara Active Pharma Sciences Limited is an Indian pharmaceutical company primarily engaged in the development, manufacture, and sale of Active Pharmaceutical Ingredients (APIs) and providing contract manufacturing and development services (CDMO) for the global pharmaceutical industry. The company focuses on a diverse portfolio of APIs across various therapeutic areas, including anti-infectives, anti-hypertensives, anti-diabetics, and central nervous system (CNS) agents.

The company was formed through the demerger of the API business from Strides Pharma Science Limited and the human API business from Amneal Pharmaceuticals Inc. (India). Solara Active Pharma Sciences Limited emphasizes strong research and development capabilities, state-of-the-art manufacturing facilities, and adherence to global regulatory standards to serve customers worldwide.

Factory or Trader

Solara Active Pharma Sciences Limited is a factory (manufacturer). It owns and operates multiple manufacturing facilities in India that are approved by various international regulatory bodies such as the US FDA, European regulatory authorities, and others. These facilities are dedicated to the large-scale production of Active Pharmaceutical Ingredients.

Solara Active Pharma Sciences Limited manufactures and sells Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates across various therapeutic areas. Their product portfolio primarily includes APIs for pain management and anti-inflammatory drugs such as Ibuprofen; anti-diabetic medications like Metformin Hydrochloride; gastrointestinal drugs including Pantoprazole Sodium Sesquihydrate; cardiovascular drugs such as Valsartan and Rosuvastatin Calcium; central nervous system drugs like Sertraline Hydrochloride and Pregabalin; anti-histamines such as Fexofenadine Hydrochloride; and anti-virals or their intermediates, for example, Favipiravir. The company also focuses on niche and high-potency APIs.